The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.
Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding .
Notice of Funding Opportunities
Title Announcement Number
Activity Code
Clinical Trials Status Expiration Date
Sort descending
Program Official
Request for Information (RFI): Opportunities and Challenges in Enabling and Advancing Precision Medicine Artificial Intelligence (AI) by Integrating Clinical Imaging with Multimodal Data NOT-RM-24-011
09/23/2024
Amanda Skarlupka, Ph.D.
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research RFA-CA-24-009 (R33 Clinical Trial Not Allowed)
R33
Clinical Trial Not Allowed
10/02/2024
Guillermo Marquez, Ph.D.
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research RFA-CA-24-008 (R61 Clinical Trial Not Allowed)
R61
Clinical Trial Not Allowed
10/02/2024
Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research RFA-CA-24-012 (R01 Clinical Trial Optional)
R01
Clinical Trial Optional
10/02/2024
Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research RFA-CA-24-014 (P50 Clinical Trial Optional)
P50
Clinical Trial Optional
10/02/2024
Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research RFA-CA-24-013 (U01 Clinical Trial Optional)
U01
Clinical Trial Optional
10/02/2024
Guillermo Marquez, Ph.D.
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research PAR-21-330 (U01 Clinical Trial Not Allowed)
U01
Clinical Trial Not Allowed
10/12/2024
Claire Zhu, Ph.D.
Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites RFA-CA-24-024 (UG1 Clinical Trial Required)
UG1
Clinical Trial Required
11/01/2024
Eva Szabo, M.D.
Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Statistical Center (DMASC) RFA-CA-24-025 (UG1 Clinical Trial Required)
UG1
Clinical Trial Required
11/01/2024
Eva Szabo, M.D.
Notice of Intent to Publish a Funding Opportunity Announcement for NCI Research Specialist (Clinician Scientist) Award NOT-CA-24-070 (R50 Clinical Trial Not Allowed)
R50
Clinical Trial Not Allowed
11/04/2024
Brandy Heckman-Stoddard, Ph.D., M.P.H.
